Clean & Clear is an American skincare brand specializing in over-the-counter dermatological products designed to treat acne and maintain clear skin, with a primary focus on adolescents and young adults.[1][2]
Originally developed by Revlon in the late 1950s as a line for oily skin care, the brand was acquired by Johnson & Johnson in 1991, which repositioned it toward acne control for teenage users.[3][4][5]
In 2023, following Johnson & Johnson's separation of its consumer health business, ownership transferred to the independent company Kenvue.[6][7]
Key product lines include foaming cleansers, treatment gels, and moisturizers featuring ingredients like salicylic acid, with the brand emphasizing accessible, effective routines backed by over 65 years of formulation experience.[2][1]
While it has maintained market leadership in teen skincare through consistent innovation and marketing, Clean & Clear has encountered notable challenges, such as voluntary recalls of facial cleansers due to microbial contamination risks and class-action lawsuits over trace benzene detected in certain acne treatments, prompting reformulations to address potential carcinogen exposure.[8][9][10]
History
Origins under Revlon
Clean & Clear originated as a skincare line developed by Revlon in the mid-1950s, targeting sensitive skin with gentle cleansing and moisturizing products.[11] The brand emphasized non-comedogenic formulas to prevent pore clogging, featuring clear packaging that highlighted the product's purity and transparency. Early formulations included liquid cleansers and lotions designed for daily use to maintain clean, residue-free skin without irritation.[12]By 1959, Revlon advertised Clean & Clear products such as lotions and shampoos, positioning them as suitable for all skin types seeking a fresh, unadulterated feel.[12] Advertisements from 1961 and 1962 promoted the cleanser for its ability to remove makeup and impurities effectively while preserving natural skin oils.[13] The line expanded to include items like Aquamarine Lotion in 1961, reflecting Revlon's focus on innovative, accessible dermatological care during the post-war consumer boom.[13]Under Revlon's ownership, Clean & Clear maintained a broad appeal for everyday skincare rather than specialized treatments, with sales driven by drugstore distribution and print media campaigns.[14] The brand's growth aligned with Revlon's diversification into personal care beyond cosmetics, though it faced competition from emerging specialized acne brands by the 1980s. In 1991, Revlon divested Clean & Clear to Johnson & Johnson, marking the end of its origins phase and enabling refocusing under new management.[13]
In 1991, Johnson & Johnson acquired the Clean & Clear brand from Revlon for an undisclosed amount, integrating it into its consumer health division to bolster its skincare offerings aimed at adolescents and young adults.[4][15] This move aligned with Johnson & Johnson's broader strategy to diversify beyond infant care into targeted dermatological products, following earlier expansions like the 1959 purchase of McNeil Laboratories.[16]Post-acquisition, Johnson & Johnson repositioned Clean & Clear from a general facial cleansing line to one emphasizing acne prevention and treatment, capitalizing on salicylic acid-based formulations to address teen-specific skin concerns such as oiliness and breakouts.[17][3] The brand's marketing shifted toward empowering young consumers with accessible, oil-free products, which helped drive sales growth; by the early 2000s, it had established a strong foothold in the over-the-counter acne market.Expansion under Johnson & Johnson included the development of sub-lines like Advantage, launched in the 2000s with targeted anti-acne items such as spot treatments, exfoliating scrubs, and non-comedogenic moisturizers containing 2% salicylic acid.[17] Product innovation continued with extensions like the Morning Burst range, which by 2011 incorporated body washes alongside facial cleansers infused with fruit extracts for a refreshing, dual-purpose appeal. These efforts contributed to Clean & Clear's global reach, including adaptations for emerging markets in Asia, while maintaining a focus on efficacy through clinical claims of reduced blemishes within days.[3]
Spin-off to Kenvue and recent developments
In 2021, Johnson & Johnson announced plans to separate its consumer health business into an independent company to focus on pharmaceuticals and medical devices. The entity was named Kenvue in September 2022, encompassing brands such as Neutrogena, Aveeno, and Clean & Clear from the skin health and beauty segment.[18] Clean & Clear, acquired by Johnson & Johnson in 1991 as part of its expansion into over-the-counter skincare, transferred to Kenvue as part of this division, which generated approximately $15 billion in annual sales prior to the split.[7]Kenvue launched its initial public offering on May 4, 2023, selling 172.8 million shares at $22 each and raising $3.8 billion, marking the largest U.S. IPO since 2021; it began trading on the New York Stock Exchange under the ticker KVUE.[19]Johnson & Johnson retained majority ownership post-IPO, but initiated an exchange offer in July 2023 to distribute at least 80.1% of Kenvue shares to its shareholders.[20] The process concluded on August 23, 2023, with Kenvue achieving full independence after Johnson & Johnson exchanged its remaining 9.5% stake.[7][21]Post-spin-off, Kenvue faced operational challenges, including a 4% decline in reported net sales for the second quarter of 2025 (organic sales down 4.2%), attributed partly to portfolio reviews and market pressures.[22] In June 2025, the company announced layoffs of 69 positions at its new Summit, New Jersey headquarters as part of global restructuring following the separation.[23] Regarding Clean & Clear, Kenvue has explored divesting smaller skin health and beauty brands, explicitly including it alongside Maui Moisture and Neostrata, to streamline its portfolio amid strategic shifts.[24] By October 2025, reports indicated broader considerations for selling or spinning off the entire skin health and beauty division, which houses Clean & Clear, though no transactions have been finalized.[25] These moves reflect Kenvue's efforts to prioritize core self-care brands like Tylenol and Band-Aid amid competitive dynamics in skincare.[24]
Product Portfolio
Core acne treatment products
Clean & Clear's core acne treatment products center on topical over-the-counter formulations featuring salicylic acid and benzoyl peroxide as active ingredients, which exfoliate pores, reduce inflammation, and combat acne-causing bacteria.[26] These products form the brand's foundational offerings for managing mild to moderate acne, typically recommended for twice-daily application as part of a basic skincare routine.[27] Key examples include spot treatments, gels, toners, and exfoliating cleansers, often available in drugstores since their introduction in the brand's early years under Revlon and later Johnson & Johnson.[28]Persa-Gel 10 is a maximum-strength acne medication cream containing 10% benzoyl peroxide, designed to penetrate deep into pores to kill Propionibacterium acnes bacteria, visibly reduce pimple size and redness within one day, and help prevent new breakouts.[28] It is classified as a keratolytic and antibacterial agent suitable for acne-prone, balanced, or combination skin types, with instructions for external use only and warnings against eye contact or application on broken skin.[28]Acne Spot Treatment features 2% salicylic acid in an oil-free gel base, which works by chemically exfoliating the skin surface to unclog pores and diminish pimpleinflammation, reportedly reducing size and redness in as little as four hours.[29] The formulation includes witch hazel and is intended for targeted application on individual blemishes to avoid over-drying surrounding skin.[30]Essentials Acne Toner contains 2% salicylic acid combined with pro-vitamin B5 (panthenol) in a fragrance-free liquid, applied post-cleansing to remove excess oil, clear blackheads, and prevent acne by penetrating and exfoliating pore linings without excessive irritation.[31]Acne Exfoliating Cleanser, also known as Triple Clear in some variants, incorporates 2% salicylic acid to treat existing acne while cleansing and preventing future outbreaks through mild mechanical and chemical exfoliation during facial washing.[32][33] These products adhere to FDA monograph standards for acne therapeutics, emphasizing non-comedogenic bases to minimize pore clogging.[34]
Specialized lines
The Essentials line targets users with sensitive or basic skincare needs, emphasizing gentle, non-irritating formulas that cleanse and moisturize without exacerbating breakouts. Key products include the Essentials Sensitive Skin Foaming Facial Cleanser, which removes dirt, oil, and makeup while preserving the skin's natural moisture barrier, and the Dual Action Moisturizer, formulated to hydrate dry areas prone to acne without clogging pores.[35][36] These items incorporate fragrance-free options with lower concentrations of active ingredients to minimize irritation, suitable for those with reactive skin types.[37]The Morning Burst line specializes in invigorating, oil-free cleansers aimed at morning routines, incorporating bursting beads with vitamin C for brightening and gentle exfoliation via BHA. Products like the Morning Burst Hydrating Facial Cleanser deep clean and refresh skin without clogging pores, while the Day & Night Cleanser 2-Pack extends utility across daily cycles.[38][27] This range addresses dullness and mild dehydration in acne-prone skin, promoting a radiant appearance through antioxidant-infused hydration rather than aggressive acne targeting.[39]Deep Action products focus on intensive pore penetration and exfoliation for thorough oil and impurity removal, particularly beneficial for oily or congested skin. The Deep Action Exfoliating Cleanser and Cream Cleanser employ cooling, oil-free formulas to unclog pores and revitalize skin without stripping natural oils excessively.[40][41] These are positioned for users seeking deeper cleansing efficacy compared to standard washes, with mechanisms that enhance penetration of active agents into pore depths.[39]Additional specialized offerings, such as the Night Relaxing Facial Cleanser, cater to evening rituals with purifying sea minerals and kelp extracts for calming and impurity removal, aiding relaxation while maintaining acne prevention.[42] While not forming a full standalone line, oily skin concerns are addressed across these ranges via targeted items like Oil Absorbing Sheets from the Classics, which instantly mattify excess sebum without disrupting the skin barrier.[39][43] Overall, these lines adapt core formulations to niche needs like sensitivity or routine-specific refreshment, prioritizing compatibility with acne-prone profiles.[27]
Discontinued and reformulated items
The Clean & Clear brand has discontinued several acne-focused products, as listed on its official discontinued products page, including the Continuous Control Acne Cleanser, which featured 10% benzoyl peroxide for persistent acne control and was recommended for replacement with the Deep Action Exfoliating Cleanser.[44] Other discontinued items include the Lemon Gel Cleanser, Lemon Zesty Scrub, and Essentials DeepCleaning Toner for Sensitive Skin, with the company directing consumers to current alternatives like the Morning Burst or Deep Action lines for similar cleansing and exfoliation benefits.[45]In June 2020, Johnson & Johnson discontinued the Clean & Clear Clear Fairness moisturizer line, marketed primarily in India, Asia, and the Middle East for its skin-lightening claims via ingredients like niacinamide; the decision followed an internal review amid growing scrutiny over the promotion of skin tone uniformity and potential reinforcement of colorism preferences in those markets.[46][47]Reformulations have targeted efficacy and sensory enhancements in select products. The Morning Burst Gel FacialCleanser was updated in early 2024 by Kenvue to incorporate vitamin C for brightening, BHA for exfoliation, and MoodScentz technology—a fragrance system designed to evoke positive emotions—while maintaining oil-free cleansing for acne-prone skin.[48] Earlier changes included the rebranding and ingredient shift of the Foaming FacialCleanser to the Essentials variant around 2012, introducing triethanolamine as the primary active for pH adjustment and foam stabilization.[49] In late 2023, broader reformulations across the lineup emphasized natural ingredients and reduced packaging, as announced via brand channels, though specific product details varied by region.[50]
Formulation and Ingredients
Active ingredients and mechanisms
Clean & Clear acne treatment products primarily utilize salicylic acid and benzoyl peroxide as active ingredients, with concentrations typically at 2% for salicylic acid in cleansers, toners, and spot treatments, and up to 10% for benzoyl peroxide in targeted gels.[31][28][51]Salicylic acid, a beta-hydroxy acid, functions through keratolytic and comedolytic actions by dissolving the intercellular cement in the stratum corneum, thereby promoting desquamation of follicular epithelium and reducing comedone formation.[52] It also exhibits mild anti-inflammatory, bacteriostatic, and fungistatic properties, which help mitigate acne inflammation without directly eradicating bacteria.[53]Benzoyl peroxide exerts its effects via oxidative mechanisms, decomposing into benzoic acid and reactive oxygen species that demonstrate bactericidal activity against Cutibacterium acnes, a key pathogen in acnepathogenesis by oxidizing bacterial proteins and lipids.[54] Additionally, it provides keratolytic benefits by loosening keratin plugs in follicles, aiding in the prevention of comedones, though its primary efficacy stems from antimicrobial action rather than exfoliation alone.[55][56]
Efficacy based on clinical data
Clinical data supporting the efficacy of Clean & Clear products primarily stem from studies on their active ingredients, benzoyl peroxide (BPO) and salicylic acid (SA), rather than brand-specific randomized controlled trials, which are scarce in peer-reviewed literature. The U.S. Food and Drug Administration (FDA) has classified both BPO (2.5%–10%) and SA (0.5%–2%) as generally recognized as safe and effective (GRASE) for over-the-counter topical treatment of acne vulgaris under the OTC Monograph for Topical Acne Drug Products, based on aggregated clinical evidence demonstrating lesion reduction in mild to moderate cases.[57][58]Benzoyl peroxide, featured in Clean & Clear formulations such as Persa-Gel (up to 10% concentration), exhibits antimicrobial activity against Cutibacterium acnes (formerly Propionibacterium acnes) and comedolytic effects, leading to reductions in inflammatory lesions. A meta-analysis of randomized trials found that 5% BPO monotherapy achieved approximately 20%–30% mean reduction in total lesions after 8–12 weeks, with greater efficacy in combinations (e.g., BPO plus topical antibiotics or retinoids) outperforming single agents.[59][60]American Academy of Dermatology guidelines strongly recommend BPO as a first-line topical therapy due to its consistent lesion clearance across studies, though irritation limits adherence in some users.[61]Salicylic acid, the primary active in many Clean & Clear cleansers and treatments (typically 2%), functions as a keratolytic agent to exfoliate the stratum corneum and unclog follicles, proving effective for comedonal acne. Clinical trials, including a 2025 study of a 2% SAgel, reported significant decreases in acnelesions (up to 40%–50% by week 4), alongside sebum regulation and improved skin barrier function without excessive drying.[62] A multitargeted SA-based regimen showed superior lesion reduction versus BPO monotherapy in mild-to-moderate acne, with 70%–80% of participants achieving clear or almost clear skin after 12 weeks.[63] However, SA's efficacy is generally modest for inflammatory lesions compared to BPO, and meta-analyses indicate it performs best in combination therapies.[64]While marketing materials for Clean & Clear cite internal consumer studies claiming rapid improvements (e.g., clearer skin in 1 day for 100% of participants), these lack independent verification and peer review, underscoring reliance on ingredient-level data.[65] Overall, evidence supports these products for mild acne management, with lesion reductions of 20%–50% over 4–12 weeks in responsive patients, but outcomes vary by acne severity, adherence, and skin type; severe cases require prescription interventions.[61]
Comparisons to competitors
Clean & Clear products predominantly rely on salicylic acid (SA) as the active ingredient for exfoliation and pore unclogging, differing from competitors like Proactiv, which centers on benzoyl peroxide (BP) for its bactericidal effects against Propionibacterium acnes.[66] Clinical evidence indicates BP reduces inflammatory acne lesions by 50-70% over 8-12 weeks in randomized trials, outperforming SA alone, which shows milder improvements primarily in non-inflammatory comedones due to its keratolytic action rather than antimicrobial properties.[67][68] In contrast, SA in Clean & Clear formulations, typically at 0.5-2%, is gentler with lower irritation rates but limited efficacy against moderate-to-severe inflammatory acne, where BP demonstrates superior lesion clearance in comparative ingredient studies.[69]
Comedolytic and anti-inflammatory; FDA-approved for acne, with studies showing 50-60% lesion reduction over 12 weeks, superior for preventing new comedones compared to SA.[68]
Initial purging, photosensitivity, dryness; less bleaching risk than BP.[71]
PanOxyl
Benzoyl Peroxide (up to 10%)
Maximum OTC strength for rapid inflammatory acne control; clinical data supports faster bacterial kill than SA-based treatments.[70]
Severe dryness and peeling, not ideal for sensitive skin.[69]
Retinoid-based options like Differin offer longer-term prevention by normalizing follicular keratinization, an advantage over Clean & Clear's SA-focused approach, which lacks comparable comedone prevention in empirical reviews from dermatological guidelines.[72] Combinations of BP with retinoids or SA, as recommended by the American Academy of Dermatology, yield better outcomes than SA monotherapy, highlighting Clean & Clear's positioning for mild, teen-oriented acne rather than versatile moderate cases addressed by multi-active competitors.[68][66] Pricing-wise, Clean & Clear remains more accessible at $5-10 per item in drugstores, versus Proactiv's subscription model averaging $20-30 monthly, though efficacy gains in competitors may justify higher costs for persistent acne.[73]
Marketing and Branding
Advertising strategies
Clean & Clear's advertising strategies emphasize digital channels and influencer collaborations to target teenagers, focusing on authenticity and product benefits like oil control and clear skin. The brand has shifted from traditional mega-influencers to micro-influencers with modest followings (around 500 followers) to foster genuine engagement, selecting participants through social media searches and local press scans. In one 2018 campaign executed with VaynerMedia, over 300 teens were initially identified, narrowed to 30 via selfie videos, and finalized to six based on peer feedback, with selected influencers like nonprofit founder Dillon Eisman creating personal content amplified on Instagram and YouTube using paid media optimized for engagement.[74]This approach yielded measurable results, including a 50% sales lift for promoted oil-absorbing sheets and an overall 19% sales increase since February 2018, particularly strong at retailers like Walmart, alongside high video views (e.g., 3.2 million for Eiseman's YouTube video) and positive comments indicating resonance with the audience.[74] Complementing this, Clean & Clear has invested in video marketing on YouTube, pioneering a comprehensive content strategy that set internal benchmarks for the parent company by integrating user-generated and branded videos to build customer journeys.[75]Region-specific tactics include social media ads featuring influencers to drive product trial. In a 2017 Facebook campaign in the MENA region, targeting girls aged 13-22 and their mothers, the brand partnered with music influencers like The 5 and Carizma via Sony Music Middle East, using video, carousel, and Instant Experience formats with youthful, emoji-driven visuals to promote liquid cleanser over bar soap. This effort reached 974,000 users, achieved a 14% ad recall rate, and boosted UAE sales by 23%, validated through Nielsen's matched panel analysis comparing test (Sharjah) and control (Abu Dhabi) markets.[76] Overall ad expenditures supported these efforts, totaling $29.1 million in 2012 before a pivot to cost-efficient digital formats.[77]
Target audiences and campaigns
Clean & Clear primarily targets adolescents and young adults with acne-prone skin, focusing on females aged 13 to 22 as core consumers through a 100% digital strategy emphasizing social media engagement.[76] The brand also appeals to college students and young working professionals seeking accessible anti-acne solutions amid a competitive skincare market.[78]Marketing campaigns leverage influencer partnerships and targeted ads on platforms like Facebook and Snapchat to drive product trials, such as liquid cleansers in the MENA region, resulting in increased sales conversions.[76][79] In 2022, the #PimpleHiTohHai initiative in India aimed to normalize acne among young girls, encouraging confidence rather than insecurity by featuring relatable scenarios of pimple management.[80]Earlier efforts included a 2019 India campaign, 'Unbottle Apna Swag', promoting face wash variants with motivational messaging to "awaken" users beyond caffeine reliance.[81] By 2014, video series avoided explicit references to "blemishes," opting for indirect empowerment narratives, supported by Johnson & Johnson advertising expenditures of $29.1 million in 2012.[77] In 2018, the C&C sub-brand extension targeted Generation Z with broader skincare items like masks and moisturizers, expanding beyond core acne treatments.[17] These strategies align with Johnson & Johnson's youth-focused segmentation for Clean & Clear within its anti-acne portfolio.[82]
Partnerships and endorsements
Clean & Clear has engaged in several celebrity endorsements and partnerships to promote its acne-focused skincare products, often targeting teenagers through campaigns emphasizing self-confidence and empowerment. In June 2010, the brand partnered with the nonprofit DoSomething.org and singer Demi Lovato to launch the "Join the Surge" initiative, aimed at mobilizing teens for community service and personal development.[83] This marked Clean & Clear's initial foray into celebrity-backed charity efforts, with Lovato appearing in promotional materials to highlight skin confidence alongside social action.[84]In 2011, Clean & Clear collaborated with the United Nations Foundation's Girl Up campaign to provide teens with resources like the Girl Up 2 Go kit, supporting global girls' education and empowerment programs.[85] The partnership included back-to-school promotions at retailers such as Target, integrating skincare messaging with advocacy for adolescent girls' rights.[86]Subsequent endorsements included musical acts: in 2015, girl group Fifth Harmony served as brand ambassadors, featuring in a campaign video that addressed acne insecurities, with member Camila Cabello sharing personal experiences to connect with young audiences.[87] That same year, transgender activist Jazz Jennings became the face of the "#SeeTheRealMe" campaign, promoting authenticity and skin acceptance in advertisements.[88][89]Product-specific collaborations extended to limited-edition items, such as the 2012 Hello Kitty Oil Absorbing Sheets released ahead of Valentine's Day, blending skincare with pop culture appeal.[90] Regionally, in 2016, Clean & Clear Middle East teamed with Arabic boy band The5 for a youth-targeted promotional campaign.[91] By 2018, the brand shifted toward digital influencers, partnering with YouTube creators Brooklyn and Bailey McKnight—who had over 5 million subscribers—for the launch of the C&C sub-brand, focusing on Gen Z skincare routines.[92] These efforts underscore Clean & Clear's strategy of aligning with youth icons to enhance brand relevance amid evolving media landscapes.
Health and Safety Evaluations
Ingredient risks and regulatory assessments
Clean & Clear products primarily feature active ingredients such as benzoyl peroxide (2.5% to 10%) and salicylic acid (0.5% to 2%), which are classified under the U.S. Food and Drug Administration's (FDA) Over-the-Counter (OTC) Monograph M006 for topical acne drug products as generally recognized as safe and effective (GRASE) when used as directed. These concentrations allow marketing without premarket approval, provided labeling complies with monograph requirements for indications, warnings, and directions.[93]Benzoyl peroxide, a key antibacterial agent in many Clean & Clear formulations, carries risks of skin irritation including dryness, peeling, redness, itching, and burning, with rare instances of severe allergic reactions such as angioedema or anaphylaxis reported in post-market surveillance.[94] In 2014, the FDA issued a safety communication highlighting rare but serious hypersensitivity reactions to OTC acne products containing benzoyl peroxide, urging discontinuation upon symptoms like throat swelling or hives and advising patch testing.[95] Recent assessments have raised concerns about benzoyl peroxide's potential decomposition into benzene—a known carcinogen—under elevated temperatures (above 78°F/25.6°C), with independent lab tests detecting variable benzene levels in some acne products after stress conditions.[96] However, FDA testing of 95 benzoyl peroxide products in 2024-2025 found elevated benzene in only six, none identified as Clean & Clear, and multiple studies conclude no elevated cancer risk from topical use, attributing systemic absorption as negligible.[97][98]Salicylic acid, functioning as a keratolytic to unclog pores, is associated with similar irritation risks including dryness, stinging, and peeling, particularly in sensitive skin, though systemic toxicity like salicylism is unlikely at OTC concentrations due to low absorption.[99] The Cosmetic Ingredient Review (CIR) Expert Panel affirmed salicylic acid safe in cosmetics at up to 2% when formulated to minimize irritation, with the European Commission's Scientific Committee on ConsumerSafety (SCCS) endorsing up to 0.5% as a preservative but higher for acne use under restricted conditions.[100] Both ingredients' combined use in Clean & Clear kits warrants caution against concurrent application with other topicals to avoid excessive irritation, as per monograph warnings.Regulatory oversight emphasizes post-market monitoring, with no Clean & Clear-specific bans or reclassifications, though inert ingredients like preservatives may pose additional sensitization risks in broader safety evaluations of acne formulations.[95] Empirical data from pharmacovigilance supports their continued OTC status, prioritizing user instructions for storage, patch testing, and discontinuation to mitigate adverse events.[101]
Recalls and quality issues
In December 2012, Johnson & Johnson Inc. initiated a voluntary recall in Canada for specific lots of Clean & Clear Advantage 3-in-1 Foaming Acne Wash (2% salicylic acid) due to potential congealing from a surfactant-fragrance interaction, which could result in uneven distribution and elevated salicylic acid concentrations in congealed portions exceeding labeled amounts.[102] Affected lots included 0021VA, 0021VB, 0041VA, and others up to 0171VA, plus certain promotional packages, classified as a Type III hazard by Health Canada with distribution limited to select provinces.[102]On September 29, 2023, Johnson & Johnson Consumer Inc. voluntarily recalled approximately 7,800 bottles of Clean & Clear Morning Burst Facial Cleanser at the wholesale level in the United States due to potential microbial contamination posing a risk of infection if used.[103] The action was precautionary, with no reported illnesses, and followed an FDA enforcement report notice; the product was discontinued thereafter.[8]Clean & Clear benzoyl peroxide-based acne products, such as Continuous Control Acne Cleanser, have faced scrutiny for potential benzene formation under certain conditions like heat exposure, as highlighted in independent lab testing by Valisure in 2021 and subsequent FDA evaluations of 95 such products.[97] In March 2024, a class action lawsuit was filed against Johnson & Johnson alleging unsafe benzene levels in Clean & Clear and Neutrogena acne treatments, claiming consumer exposure to the carcinogen without adequate warnings.[104] However, FDA testing in early 2025 found elevated benzene in only 6 of 95 tested products—none specified as Clean & Clear—leading to retail-level recalls for those items but not others, with over 90% showing undetectable or low levels and minimal cancer risk from typical use.[97]Additionally, in 2014, the FDA issued a safety communication warning of rare but serious hypersensitivity reactions (e.g., severe redness, burning, blistering) to topical benzoyl peroxide products including certain Clean & Clear formulations, which may occur minutes to days after application, though no recall was mandated.[95] No widespread quality issues beyond these incidents have been documented in regulatory records.
Lawsuits and consumer claims
In March 2024, Johnson & Johnson faced a class action lawsuit alleging that its Clean & Clear acne treatment products, which contain benzoyl peroxide, exposed consumers to benzene—a known carcinogen—due to the ingredient's degradation when exposed to heat or sunlight.[9] The suit, filed in the U.S. District Court for the Eastern District of New York, claimed that the company failed to warn users of this risk, potentially leading to long-term health hazards including cancer, and sought damages for purchasers nationwide.[105] This litigation stemmed from independent testing by Valisure, a lab that petitioned the FDA in 2021 after detecting benzene in some benzoyl peroxide-based acne products at levels up to 248 times the FDA's recommended limit of 2 parts per million for pharmaceuticals, though Clean & Clear-specific tests reportedly showed levels below this threshold in certain analyses.[106][107]The FDA's subsequent investigation, completed by March 2025, tested over 150 benzoyl peroxide products and found that more than 90% had undetectable or extremely low benzene levels, contradicting broader claims of widespread contamination and prompting only limited voluntary recalls for a small number of affected items.[97] Despite this, multiple similar class actions continued against Johnson & Johnson, including for Clean & Clear Continuous Control Acne Cleanser and other variants, asserting strict liability for defective design and failure to disclose risks, with plaintiffs arguing that even trace benzene accumulation over time poses harm.[108] Courts have not yet ruled on the merits, but the suits highlight ongoing debates over benzoyl peroxide stability, as peer-reviewed studies confirm benzene formation under certain storage conditions while emphasizing variable exposure risks.[109]Separate consumer claims emerged in a 2020 class action challenging Clean & Clear's "oil-free" labeling, alleging that products like Oil-Free Foaming Facial Cleanser contained emollients such as isostearyl palmitate, which function as oils and contradicted marketing that promised non-comedogenic benefits for acne-prone skin.[110] The suit, covering purchases from 2015 onward, accused Johnson & Johnson of false advertising under consumer protection laws, but it primarily targeted Neutrogena with Clean & Clear as a co-branded example; resolution details remain limited, with no major settlements reported specific to Clean & Clear. Individual consumer complaints, often filed via regulatory bodies like the FDA's MedWatch, have included reports of skin irritation, burns, or allergic reactions to ingredients like salicylic acid or benzoyl peroxide in Clean & Clear formulations, though these lack consolidated litigation and are not deemed systemic by health authorities. No large-scale verdicts or payouts have been awarded against the brand for these issues as of October 2025.
Environmental and Broader Impacts
Microbeads and pollution concerns
Clean & Clear exfoliating products, such as facial scrubs, historically incorporated plastic microbeads—tiny polyethylene spheres under 5 mm in diameter—intended as abrasives for skin cleansing.[111] These microbeads, present in formulations like the Blackhead Eraser Scrub, numbered approximately 330,000 per tube, contributing to their widespread use in personal care items before regulatory scrutiny intensified.[111]Upon rinsing, microbeads enter wastewater systems, where conventional treatment plants capture only 2–10% of them, allowing the remainder to discharge into rivers, lakes, and oceans.[112] A single wash can release up to 94,500 microbeads, exacerbating microplastic accumulation in aquatic environments.[112] These non-biodegradable particles adsorb persistent organic pollutants, which bioaccumulate in organisms ingesting them, such as zooplankton and fish, potentially disrupting food chains and transferring toxins to higher trophic levels including humans.[112] Empirical studies confirm their persistence in marine sediments and biota, linking them to reduced feeding efficiency and physiological stress in aquatic species.[112]The environmental risks prompted legislative action, including the U.S. Microbead-Free Waters Act of 2015, which prohibited the manufacture and sale of rinse-off cosmetics containing intentionally added plastic microbeads by July 2018.[113] This directly impacted brands like Clean & Clear, owned by Johnson & Johnson, alongside competitors such as Neutrogena and Clinique, necessitating reformulation to natural alternatives like jojoba or sugar beads.[114] Similar bans emerged globally, with the UK pledging elimination by 2017, reflecting consensus on microbeads as a preventable source of plastic pollution despite industry lobbying for bioplastic substitutes, which studies indicate degrade incompletely in marine settings.[115] Post-ban, legacy pollution persists, with microbeads detected in global waterways years after phase-out.[112]
Sustainability efforts
Johnson & Johnson, parent company to the Clean & Clear skincare brand, pursues environmental sustainability through enterprise-wide goals applicable to its Consumer Health division, which includes Clean & Clear products. These encompass a commitment to 100% renewable electricity sourcing globally and absolute reductions in Scope 1 and 2 greenhouse gas emissions, building on over two decades of climate action reported in 2024.[116][117]For packaging, Johnson & Johnson set targets in 2020 for its consumer brands to achieve 100% recyclable, reusable, or compostable plastic packaging, alongside incorporating certified post-consumer recycled content where feasible; these apply to Clean & Clear's tubes, bottles, and kits, though specific compliance metrics for the brand remain undisclosed in public reports.[118] Earlier efforts included a 2008 redesign of Clean & Clear's Acne Kit packaging, which integrated sustainable guidelines such as sourcing from renewable energy-powered facilities and prioritizing recycled or biodegradable materials to minimize environmental impact.[119]Broader product sustainability under Johnson & Johnson emphasizes decarbonizing the supply chain and reducing waste across consumer portfolios, with Clean & Clear benefiting indirectly through shared initiatives like supplier engagement for emissions cuts.[117] However, brand-specific advancements, such as bio-based ingredients or refill systems for Clean & Clear formulations, are not documented in recent corporate disclosures. Independent assessments critique the brand's environmental record, noting contributions to plastic pollution via non-organic, synthetic-heavy products and insufficient transparency on waste metrics.[3][120]
Market reception and criticisms
Clean & Clear has maintained a significant presence in the mass-market acne treatment segment, particularly among teenagers and young adults seeking affordable over-the-counter solutions. As of 2018, its core acne products experienced substantial growth, with sales increasing over 270% in the 52 weeks ending April 22, according to IRI data, reflecting strong demand for benzoyl peroxide-based treatments like the Advantage line.[17] However, by 2023, the brand's U.S. sales declined by 8.6%, amid broader shifts toward clinical and premium skincare options, though it remains a staple in retail channels due to its accessibility and targeted marketing to Gen Z consumers.[121]Consumer reception is mixed, with praise for its efficacy in controlling oil and mild acne for oily skin types. Many users report reduced breakouts and a fresh feel after consistent use, attributing success to active ingredients like benzoyl peroxide in products such as Continuous Control Cleanser.[122] Aggregated reviews on platforms like MouthShut yield an average rating of 3.8 out of 5, highlighting its cost-effectiveness for budget-conscious youth.[123] In targeted campaigns, such as influencer-driven ads in the UAE, the brand boosted cleanser sales by 23%, underscoring responsiveness to digital marketing.[76]Criticisms center on its harsh formulation, which often leads to over-drying and irritation, particularly for those with sensitive or dry skin. Numerous consumer reports note stripped natural oils, resulting in rebound oiliness, peeling, or exacerbated breakouts after initial use, as the cleansers have a high pH around 8, comparable to detergents.[124] Dermatological advice cautions against it for non-oily skin types, recommending avoidance to prevent barrier damage from sulfates and alcohols.[125] Effectiveness varies individually, with some long-term users finding it superior to generics for acne control, while others experience no sustained benefits and prefer gentler alternatives.[126] These issues stem causally from aggressive exfoliation and antimicrobial agents that disrupt skin microbiome balance without adequate moisturization in the lineup.[127]